Scientific Advisory Board

Christopher C Thompson, MD FACG AGAF FASGE

Christopher Thompson, MD, MHES

Gastroenterologist, Boston, MA, U.S.A

Dr. Thompson is the director of Therapeutic Endoscopy at Brigham Women’s Hospital and an associate professor of Medicine at Harvard Medical School in Massachusetts. He is also the current chair of the Association of Bariatric Endoscopy (ABE). He started his career in medicine after receiving his MD from Pennsylvania State University, College of Medicine in Hershey, Pennsylvania. He went on to receive his MSc in health evaluation science.
Dr. Thompson has more than 200 academic publications to his name, and he has been the PI in numerous clinical trials. He is particularly well-known for his work on metabolic therapies for obesity. He is the editor of the first textbook on bariatric endoscopy, and he has trained numerous fellows in the field.

“EndoBarrier is an exciting and novel technology that fills a rapidly expanding treatment gap in the management of type 2 diabetes and obesity. The GI Dynamics team has pioneered the advancement of our understanding of disease and treatment mechanisms over the past decade, and this device holds tremendous promise,” said Dr. Thompson. “I am thrilled to be joining such an accomplished group of clinicians and look forward to collaborating with them.”

<< Back to Scientific Advisory Board